As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/20/19  Savient Pharmaceuticals Inc.      CT ORDER               1:97K                                    SEC #7                   
 5/23/17  Savient Pharmaceuticals Inc.      CT ORDER               1:15K                                    SEC #7                   
 5/30/14  Savient Pharmaceuticals Inc.      8-K:7,9     5/30/14    2:1.6M                                   Donnelley … Solutions/FA 
 5/20/14  Savient Pharmaceuticals Inc.      8-K:1,3,7,9 5/19/14    3:1.9M                                   Donnelley … Solutions/FA 
 4/17/14  Savient Pharmaceuticals Inc.      8-K:7,9     4/17/14    2:1.1M                                   Donnelley … Solutions/FA 
 3/21/14‡ Savient Pharmaceuticals Inc.      8-K:7,9     3/20/14    2:1M                                     Donnelley … Solutions/FA 
 3/18/14  Savient Pharmaceuticals Inc.      8-K:7,9     3/18/14    3:929K                                   Donnelley … Solutions/FA 
 2/21/14‡ Savient Pharmaceuticals Inc.      8-K:7,9     2/20/14    2:1.1M                                   Donnelley … Solutions/FA 
 2/14/14  Wellington Management Group LLP   SC 13G/A               1:15K  Savient Pharmaceuticals Inc.                               
 2/11/14  Franklin Resources Inc.           SC 13G/A               1:197K Savient Pharmaceuticals Inc.                               
 2/11/14  Vanguard Group Inc.               SC 13G/A               1:51K  Savient Pharmaceuticals Inc.      Vanguard Horizon Funds   
 2/11/14  Savient Pharmaceuticals Inc.      8-K:7,9     2/10/14    3:973K                                   Donnelley … Solutions/FA 
 1/22/14  Savient Pharmaceuticals Inc.      8-K:7,9     1/21/14    2:1.1M                                   Donnelley … Solutions/FA 
 1/10/14  Savient Pharmaceuticals Inc.      8-K:1,2,5,9  1/8/14    2:30K                                    Donnelley … Solutions/FA 
  1/7/14  Savient Pharmaceuticals Inc.      8-K:7,9      1/6/14    2:177K                                   Donnelley … Solutions/FA 
12/31/13  Savient Pharmaceuticals Inc.      8-K:7,9    12/30/13    2:175K                                   Donnelley … Solutions/FA 
12/20/13  Savient Pharmaceuticals Inc.      8-K:7,9    12/20/13    2:1M                                     Donnelley … Solutions/FA 
12/16/13‡ Savient Pharmaceuticals Inc.      8-K:1,9    12/10/13    3:341K                                   Donnelley … Solutions/FA 
 12/5/13  Savient Pharmaceuticals Inc.      8-K:7,9     12/5/13    2:566K                                   Donnelley … Solutions/FA 
 12/5/13  Thompson Virgil                   4          Director²   1:4K   Savient Pharmaceuticals Inc.      R R Donnelley … Filer/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	CT ORDER	SEC Confidential Treatment Order.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.